Orion, Danilo L.
HRN: 04-91-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2022
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
08/22/2022
08/28/2022
PO
5ml
Q8
Multiple Oral Ulcerated Lesions
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueEye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes